Latest Breaking News On - Weissbiotech gmbh - Page 1 : comparemela.com

BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy

EQS-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year ReportBRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy 25.05.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG stays on solid growth path.

United kingdomUnited statesWeissbiotech gmbMartina schusterLa schmitt gmbAdriaan moelkerStephanie konleBiosun biochemicals incStandard of the frankfurt stock exchangeGerman federal ministry of educationPr corporate communicationsDistribution servicesBiotech holdingBiocatalysts ltdBiotech groupHalf year

BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy

EQS-News: BRAIN Biotech AG / Key word: Mergers & Acquisitions/Strategic Company Decision BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its. | May 24, 2023

United statesUnited kingdomStephanie konleMartina schusterAdriaan moelkerWeissbiotech gmbMichael schneidersBiocatalysts ltdPr corporate communicationsBiosun biochemicals incStandard of the frankfurt stock exchangeBiotech groupCapital markets dayOne bioproducts strategyBiosun biochemicalsWeissbiotech gmbh

EQS-News: BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy

EQS-News: BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMartina schusterAdriaan moelkerWeissbiotech gmbMichael schneidersStephanie konleBiotech groupBiocatalysts ltdStandard of the frankfurt stock exchangeBiosun biochemicals incPr corporate communicationsCapital markets dayOne bioproducts strategyBiosun biochemicalsWeissbiotech gmbh

BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

23.02.2022 BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting | BRAIN Biotech AG | News | Nachricht | Mitteilung

United statesUnited kingdomLukas linnigWeissbiotech gmbAdriaan moelkerMichael schneidersStephanie konleSolascure ltdEuropean patent officePr corporate communicationsBiosun biochemicals incStandard of the frankfurt stock exchangeMarine research instituteVery dynamic startFiscal yearEngineered cas

BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

DGAP-News: BRAIN Biotech AG / Key word: Quarter Results/Forecast BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting 23.02.2022 / 07:30 The issuer. | February 23, 2022

United statesUnited kingdomLukas linnigWeissbiotech gmbAdriaan moelkerMichael schneidersStephanie konleSolascure ltdEuropean patent officePr corporate communicationsBiosun biochemicals incStandard of the frankfurt stock exchangeMarine research instituteVery dynamic startFiscal yearEngineered cas